617 related articles for article (PubMed ID: 24535691)
1. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of cidofovir in an HIV infected patient with an acyclovir and foscarnet resistant herpes simplex virus infection].
Saint-Léger E; Fillet AM; Malvy D; Rabanel B; Caumes E
Ann Dermatol Venereol; 2001; 128(6-7):747-9. PubMed ID: 11460038
[TBL] [Abstract][Full Text] [Related]
4. Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
Sauerbrei A; Bohn K; Heim A; Hofmann J; Weissbrich B; Schnitzler P; Hoffmann D; Zell R; Jahn G; Wutzler P; Hamprecht K
Antivir Ther; 2011; 16(8):1297-308. PubMed ID: 22155911
[TBL] [Abstract][Full Text] [Related]
5. Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
Arnulf B; Chebbi F; Lefrere F; Ait Arkoub Z; Varet B; Fillet AM
Bone Marrow Transplant; 2001 Oct; 28(8):799-801. PubMed ID: 11781635
[TBL] [Abstract][Full Text] [Related]
6. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
[TBL] [Abstract][Full Text] [Related]
7. Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
Muluneh B; Dean A; Armistead P; Khan T
J Oncol Pharm Pract; 2013 Jun; 19(2):181-5. PubMed ID: 22635417
[TBL] [Abstract][Full Text] [Related]
8. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP
Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393
[TBL] [Abstract][Full Text] [Related]
9. Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Voigt S; Hofmann J; Edelmann A; Sauerbrei A; Kühl JS
Transpl Infect Dis; 2016 Oct; 18(5):791-794. PubMed ID: 27482652
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir.
Stryjewski TP; Scott NL; Barshak MB; Tobin EH; Mali JO; Young LH; Foster CS; Kim IK; Durand ML
Ocul Immunol Inflamm; 2018; 26(2):199-203. PubMed ID: 27598973
[TBL] [Abstract][Full Text] [Related]
12. [Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].
Casassa EA; Nicol P; Viraben R; Gaudin C; Bulai Livideanu C; Mengelle C; Lamant L; Fortenfant F; Paul C; Konstantinou MP
Ann Dermatol Venereol; 2018 Mar; 145(3):182-186. PubMed ID: 29221652
[TBL] [Abstract][Full Text] [Related]
13. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
14. Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
Chen Y; Scieux C; Garrait V; Socié G; Rocha V; Molina JM; Thouvenot D; Morfin F; Hocqueloux L; Garderet L; Espérou H; Sélimi F; Devergie A; Leleu G; Aymard M; Morinet F; Gluckman E; Ribaud P
Clin Infect Dis; 2000 Oct; 31(4):927-35. PubMed ID: 11049772
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
Schmit I; Boivin G
J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
[TBL] [Abstract][Full Text] [Related]
16. Management of acyclovir-resistant herpes simplex virus.
Chilukuri S; Rosen T
Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus resistance to antiviral drugs.
Morfin F; Thouvenot D
J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
Lascaux AS; Caumes E; Deback C; Melica G; Challine D; Agut H; Lévy Y
J Med Virol; 2012 Feb; 84(2):194-7. PubMed ID: 22170537
[TBL] [Abstract][Full Text] [Related]
20. Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Tan HH; Goh CL
Am J Clin Dermatol; 2006; 7(1):13-29. PubMed ID: 16489840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
